4D Molecular Therapeutics stock price
NASDAQ:FDMT · Nasdaq · Healthcare · sector #164D Molecular Therapeutics's chart data is dated 2026-10-21. There is no active technical signal. There are 6 published signal records.
4D Molecular Therapeutics last closed at $12.62 (-3.66%) on 2026-10-21. Listed on Nasdaq. Trailing 12 months PER is -4.9×. Its overall grade ranks 434 of 727 stocks in Healthcare.
About this company
4D Molecular Therapeutics last closed at $12.62 (-3.66%) on 2026-10-21. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B- · 434/727
Valuation grade B
Related stocks
- RocheCustomer
- Astellas PharmaCustomer
- Sarepta TherapeuticsCustomer
ETFs holding this stock
Virtus LifeSci Biotech Clinical Trials ETF
Details →About 4D Molecular Therapeutics
- What technical signals does 4D Molecular Therapeutics (FDMT) have?
- 4D Molecular Therapeutics current technical signals: no active technical signal.
- Is 4D Molecular Therapeutics a cup-and-handle pattern?
- No. 4D Molecular Therapeutics has no valid Cup signal right now.
- What published figures are available for 4D Molecular Therapeutics?
- Market cap: $721.04M. Trailing 12 months PER: -4.9×. Latest quarter PBR: 2.18×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-22 dataset
Turn what you saw on this name into a strategy
Ask Q about 4D Molecular Therapeutics, or open the plan table on the main site.
Ask Q about 4D Molecular Therapeutics.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.